Synthesis of 1-(3,4-Dihydroxy-5-nitrophenyl)-2-phenyl-ethanone and Derivatives as Potent and Long-Acting Peripheral Inhibitors of Catechol-O-methyltransferase
- 22 December 2001
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 45 (3) , 685-695
- https://doi.org/10.1021/jm0109964
Abstract
A homologous series of novel nitro-catechol structures (7a−7e) were synthesized and tested as inhibitors of the enzyme catechol-O-methyltransferase (COMT). Increasing chain length was found to have significant impact on both brain penetration and duration of COMT inhibition in the rat. Of this series, compound 7b (1-(3,4-dihydroxy-5-nitrophenyl)-2-phenyl-ethanone) was found to exhibit the most potent and selective inhibition of peripheral COMT, with an inhibition profile more similar to entacapone 2 than tolcapone 1 (an equipotent peripheral and central inhibitor) but with much improved duration of action (7b, 70% inhibition and 2, 25% inhibition at 9 h after administration). The effects of structural modifications to 7b on COMT inhibitory profile were investigated, and it is concluded that the carbonyl group and preferably unsubstituted aromatic ring are essential features to maintain prolonged peripheral COMT inhibition. The introduction of the α-methylene group, the major structural difference between 7b and 1, would appear responsible for the observed enhancement in selectivity of peripheral COMT inhibition of 7b, which has more limited access to the brain than 1.Keywords
This publication has 19 references indexed in Scilit:
- Tolcapone and fulminant hepatitisThe Lancet, 1998
- A pilot evaluation of the tolerability, safety, and efficacy of tolcapone alone and in combination with oral selegiline in untreated Parkinson's disease patientsMovement Disorders, 1998
- The Preparation of 2-(2-Oxo-2-Phenylethyl) Benzoic Acids from DilithiatedOrtho-Toluic Acid.Synthetic Communications, 1996
- Rationale for Selective COMT Inhibitors as Adjuncts in the Drug Treatment of Parkinson's DiseaseBasic & Clinical Pharmacology & Toxicology, 1990
- Catechol‐O‐methyltransferase‐Inhibiting Pyrocatechol Derivatives: Synthesis and Structure‐Activity StudiesHelvetica Chimica Acta, 1989
- Synthesis of some novel potent and selective catechol O-methyltransferase inhibitorsJournal of Medicinal Chemistry, 1989
- New selective COMT inhibitors: useful adjuncts for Parkinson's disease?Trends in Pharmacological Sciences, 1989
- A double‐blind comparison of levodopa, madopa, and sinemet in Parkinson diseaseAnnals of Neurology, 1978
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Peripheral Aromatic L-Amino Acids Decarboxylase Inhibitor in Parkinsonism. I. EFFECT ON O-METHYLATED METABOLITES OF L-DOPA-2-14CJournal of Clinical Investigation, 1972